AlzChem Group AG Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 62 Fair Values set on narratives written by author
ACT Community Narratives
ACT: Profitability Improvements And Product Launch Partnerships Will Support Fair Valuation
Rising Global Protein Demand Will Fuel Sustainable Specialty Chemicals
Rising Environmental Mandates And Input Costs Will Squeeze Margins
Rising Global Protein Demand Will Fuel Sustainable Specialty Chemicals
View narrativeACT: Profitability Improvements And Product Launch Partnerships Will Support Fair Valuation
View narrativeRising Environmental Mandates And Input Costs Will Squeeze Margins
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
ACT: Integrated Calcium Chain And US Expansion Will Support Future Cash Flows
ACT: Niche Calcium Chain Platform And Dividend Policy Will Shape 2026 Outlook
ACT: Specialty Platform And Value Chain Position Will Shape Cash Flow And Dividend
Snowflake Analysis
AlzChem Group AG Key Details
- 6.69
- 65.63%
- 11.41%
- 32.4%
About ACT
- Founded
- 1908
- Employees
- 1680
- CEO
- Website
View website
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS – BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.